Medication Use During Pregnancy in the Intensive Care Unit

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

We summarized the medical literature regarding the safety in pregnancy of medications used in intensive care units. When considering their use, we have to weigh the benefit to the pregnant woman against the risk to the embryo and fetus. While most drugs can be used in pregnancy, it is important to avoid using those that might adversely affect the fetus, replacing them by drugs with similar pharmacologic actions. This is especially important for antiepileptic drugs, as one has to avoid using the more teratogenic drugs like valproic acid, replacing them by less teratogenic drugs such as lamotrigine or levetiracetam (Keppra).
Original languageAmerican English
Title of host publicationPrinciples and Practice of Maternal Critical Care
EditorsSharon Einav, Carolyn F. Weiniger, Ruth Landau
Place of PublicationCham
PublisherSpringer International Publishing AG
Pages535-554
Number of pages20
ISBN (Print)978-3-030-43477-9
DOIs
StatePublished - 2020

Fingerprint

Dive into the research topics of 'Medication Use During Pregnancy in the Intensive Care Unit'. Together they form a unique fingerprint.

Cite this